Charis-1000

N/A

Report date: 2023/01/29 20:00:19
NME

Base Information

Drug NameCharis-1000
Drug Alias NameCharis-1000C 1KC1K
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsol Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsol Biosciences Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A